Martin Prusinkiewicz, PhD

Postdoctoral Fellow, UBC

Menu

Metabolic Reprogramming of the Host Cell by Human Adenovirus Infection


Journal article


Martin A. Prusinkiewicz, J. Mymryk
Viruses, 2019

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Prusinkiewicz, M. A., & Mymryk, J. (2019). Metabolic Reprogramming of the Host Cell by Human Adenovirus Infection. Viruses.


Chicago/Turabian   Click to copy
Prusinkiewicz, Martin A., and J. Mymryk. “Metabolic Reprogramming of the Host Cell by Human Adenovirus Infection.” Viruses (2019).


MLA   Click to copy
Prusinkiewicz, Martin A., and J. Mymryk. “Metabolic Reprogramming of the Host Cell by Human Adenovirus Infection.” Viruses, 2019.


BibTeX   Click to copy

@article{martin2019a,
  title = {Metabolic Reprogramming of the Host Cell by Human Adenovirus Infection},
  year = {2019},
  journal = {Viruses},
  author = {Prusinkiewicz, Martin A. and Mymryk, J.}
}

Abstract

Viruses are obligate intracellular parasites that alter many cellular processes to create an environment optimal for viral replication. Reprogramming of cellular metabolism is an important, yet underappreciated feature of many viral infections, as this ensures that the energy and substrates required for viral replication are available in abundance. Human adenovirus (HAdV), which is the focus of this review, is a small DNA tumor virus that reprograms cellular metabolism in a variety of ways. It is well known that HAdV infection increases glucose uptake and fermentation to lactate in a manner resembling the Warburg effect observed in many cancer cells. However, HAdV infection induces many other metabolic changes. In this review, we integrate the findings from a variety of proteomic and transcriptomic studies to understand the subtleties of metabolite and metabolic pathway control during HAdV infection. We review how the E4ORF1 protein of HAdV enacts some of these changes and summarize evidence for reprogramming of cellular metabolism by the viral E1A protein. Therapies targeting altered metabolism are emerging as cancer treatments, and similar targeting of aberrant components of virally reprogrammed metabolism could have clinical antiviral applications.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in